Read more
Informationen zum Autor Karl V Clemons, Stanford University, Stanford, California. Malcolm Richardson, University of Manchester, Manchester, United Kingdom. David S Perlin, UMDNJ-New Jersey Medical School, Newark, New Jersey. Klappentext "The papers included in two volumes of Annals of the New York Academy of Sciences provide a cross-section of the information presented at the 5th 'Advances Against Aspergillosis'"--Page viii. Zusammenfassung Aspergillosis! the leading fungal cause of mortality in immunocompromised patients! presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Inhaltsverzeichnis Preface for Advances Against Aspergillosis Karl V. demons David S. Perlin Malcolm Richardson vii Aspergillosis in the Clinic Application of diagnostic markers to invasive aspergillosis in children Emmanuel Roilides Zoi-Dorothea Pana 1 Azole resistance in Aspergillus: global status in Europe and Asia Sevtap Arikan-Akdagli 9 The impact of azole resistance on aspergillosis guidelines Sarah P. Georgiadou Dimitrios P. Kontoyiannis 15 Risk stratification for invasive aspergillosis in immunocompromised patients Raoul Herbrecht Pierre Bories Jean-Charles Moulin Marie-Pierre Ledoux Valérie Letscher-Bru 23 Invasive aspergillosis in the intensive care unit George Dimopoulos Frantezeska Frantzeskaki Garyfallia Poulakou Apostolos Armaganidis 31 Management of chronic pulmonary aspergillosis Koichi Izumikawa Masato Tashiro Shigeru Kohno 40 The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis Richard B. Moss 49 Multifocal pulmonary aspergillomas: case series and review Matthew Pendleton David W. Denning 58 Immune regulation in idiopathic bronchiectasis Rosemary J. Boyton Daniel M. Altmann 68 Aspergillus bronchitis without significant immunocompromise Ales Chrdle Sahlawati Mustakim Rowland J. Bright-Thomas Caroline G. Baxter Timothy Felton David W. Denning 73 ...
